Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran
Year of publication: |
2023
|
---|---|
Authors: | Ravangard, Ramin ; Jalali, Farideh Sadat ; Hajahmadi, Marjan ; Jafari, Abdosaleh |
Published in: |
Health economics review. - Heidelberg : Springer, ISSN 2191-1991, ZDB-ID 2634483-X. - Vol. 13.2023, 1, Art.-No. 44, p. 1-11
|
Subject: | Valsartan | Enalapril | Candesartan | Markov model | Heart failure | Cost-utility analysis | Kosten-Nutzen-Analyse | Cost-benefit analysis | Iran | Herzkrankheit | Heart disease |
-
Estler, Bent, (2023)
-
Using electronic medical records in admission decisions : a cost effectiveness analysis
Ben-Assuli, Ofir, (2013)
-
Money for health : the compensating variation of cardiovascular diseases
Groot, Wim, (2002)
- More ...
-
Economic burden of multiple sclerosis: A cross-sectional study in Iran
Rezaee, Mehdi, (2022)
-
Economic burden of multiple sclerosis : a cross-sectional study in Iran
Rezaee, Mehdi, (2022)
-
Ravangard, Ramin, (2014)
- More ...